BridgeMD
Compares treatment options for Non-ST-elevation Myocardial Infarction
Official title Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI
ClinicalTrials.gov ID: NCT05786131
What this study is testing
- What it's testing
- Prospective, randomized, controlled, multicenter, open-label trial to study whether multivessel percutaneous coronary intervention (PCI) is superior over culprit-lesion only PCI in patients with non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel coronary artery disease.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- NSTEMI as suggested by high-sensitivity troponin algorithms
- Multivessel coronary artery disease
- Identifiable culprit lesion
- Informed consent
You likely can't join if
- Age \<18 years
- Cardiogenic shock
- Sustained ventricular tachycardia (VT) or ventricular fibrillation (VF)
- Contraindication for coronary revascularization
- Prior coronary artery bypass graft
- Indication for coronary artery bypass graft surgery
See the full eligibility criteria
- NSTEMI as suggested by high-sensitivity troponin algorithms
- Multivessel coronary artery disease
- Identifiable culprit lesion
- Informed consent
- Age \<18 years
- Cardiogenic shock
- Sustained ventricular tachycardia (VT) or ventricular fibrillation (VF)
- Contraindication for coronary revascularization
- Prior coronary artery bypass graft
- Indication for coronary artery bypass graft surgery
- Non-culprit lesion located in the left main coronary artery
- Co-morbidity with life expectancy less than 6 months
- Type 2 myocardial infarction
- Pregnancy and breast feeding period
The study team makes the final eligibility decision.
Where it's taking place
- Graz, Austria
- Innsbruck, Austria
- Vienna, Austria
- Bad Berka, Germany
- Bad Krozingen, Germany
- Bad Nauheim, Germany
- Bad Oeynhausen, Germany
- Berlin, Germany
- Bielefeld, Germany
- Bochum, Germany
- Bremen, Germany
- Dessau, Germany
- Dortmund, Germany
- Dresden, Germany
- Düsseldorf, Germany
- Erfurt, Germany
- Erlangen, Germany
- Essen, Germany
- Freiburg im Breisgau, Germany
- Fulda, Germany
+ 30 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Graz, Austria; Innsbruck, Austria; Vienna, Austria; Bad Berka, Germany; Bad Krozingen, Germany; Bad Nauheim, Germany and 44 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.